Published in Antimicrob Agents Chemother on February 01, 2005
Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol (2009) 2.01
Key role of Mfd in the development of fluoroquinolone resistance in Campylobacter jejuni. PLoS Pathog (2008) 1.19
Campylobacter coli in swine production: antimicrobial resistance mechanisms and molecular epidemiology. J Clin Microbiol (2005) 1.08
Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int (2013) 1.05
Resistance mechanisms in Campylobacter jejuni. Virulence (2013) 1.04
Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob Agents Chemother (2007) 1.02
Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones. Antimicrob Agents Chemother (2005) 0.99
Cryptic ecology among host generalist Campylobacter jejuni in domestic animals. Mol Ecol (2014) 0.97
Fluoroquinolone use in food animals. Emerg Infect Dis (2005) 0.95
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother (2009) 0.85
Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta. Epidemiol Infect (2007) 0.82
Exploiting Bacterial Whole-Genome Sequencing Data for Evaluation of Diagnostic Assays: Campylobacter Species Identification as a Case Study. J Clin Microbiol (2016) 0.79
The Risk of Some Veterinary Antimicrobial Agents on Public Health Associated with Antimicrobial Resistance and their Molecular Basis. Front Microbiol (2016) 0.75
The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature (2000) 17.14
Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med (1999) 6.20
Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis (2001) 5.41
Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother (1996) 4.15
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob Agents Chemother (1993) 3.86
Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother (1991) 3.71
CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother (2002) 3.31
Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother (1996) 2.64
Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. J Clin Microbiol (1998) 2.14
Phage typing of Campylobacter jejuni and Campylobacter coli and its use as an adjunct to serotyping. Epidemiol Infect (1999) 2.03
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother (2003) 1.71
Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J Antimicrob Chemother (1996) 1.69
Specific PCR identification and differentiation of the thermophilic campylobacters, Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J Clin Microbiol (1999) 1.66
Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother (2001) 1.62
Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother (1991) 1.55
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53
Applicability of a rapid duplex real-time PCR assay for speciation of Campylobacter jejuni and Campylobacter coli directly from culture plates. FEMS Microbiol Lett (2003) 1.48
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother (2001) 1.46
Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J Clin Microbiol (2002) 1.42
Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother (1995) 1.38
Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother (2003) 1.35
Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. J Clin Microbiol (1999) 1.32
Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett (2002) 1.31
Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay. J Clin Microbiol (2000) 1.27
Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microb Drug Resist (2001) 1.26
Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR. FEMS Microbiol Lett (2000) 1.24
Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997. J Clin Pathol (1999) 1.23
Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob Agents Chemother (1998) 1.22
Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerg Infect Dis (2003) 1.17
Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J Antimicrob Chemother (2003) 1.11
Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb Drug Resist (2002) 1.07
Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones. Antimicrob Agents Chemother (2005) 0.99
Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing. J Clin Lab Anal (1996) 0.98
gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing. Antimicrob Agents Chemother (2002) 0.94
Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother (2004) 0.93
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999. J Vet Med Sci (2001) 0.92
Use of a LightCycler gyrA mutation assay for identification of ciprofloxacin-resistant Campylobacter coli. FEMS Microbiol Lett (2002) 0.84
Quinolone resistance and Campylobacter. Clin Microbiol Infect (1999) 0.81
The comprehensive antibiotic resistance database. Antimicrob Agents Chemother (2013) 6.41
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Comparative genome analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 provides insights into evolutionary and host adaptation pathways. Genome Res (2008) 3.54
A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. Emerg Infect Dis (2002) 3.18
Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother (2004) 1.96
Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr Opin Microbiol (2009) 1.79
Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob Agents Chemother (2004) 1.66
Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother (2006) 1.65
Salmonella bongori provides insights into the evolution of the Salmonellae. PLoS Pathog (2011) 1.52
The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol (2006) 1.51
Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother (2006) 1.51
Applicability of a rapid duplex real-time PCR assay for speciation of Campylobacter jejuni and Campylobacter coli directly from culture plates. FEMS Microbiol Lett (2003) 1.48
Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J Clin Microbiol (2002) 1.42
Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2002) 1.34
Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol Lett (2002) 1.31
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother (2008) 1.31
Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother (2007) 1.27
Complete sequence and molecular epidemiology of IncK epidemic plasmid encoding blaCTX-M-14. Emerg Infect Dis (2011) 1.25
Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother (2008) 1.23
RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol (2010) 1.23
Fluorescent amplified fragment length polymorphism genotyping of Campylobacter jejuni and Campylobacter coli strains and its relationship with host specificity, serotyping, and phage typing. J Clin Microbiol (2004) 1.21
A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. J Antimicrob Chemother (2010) 1.20
The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol (2009) 1.20
Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrob Agents Chemother (2006) 1.16
Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl Environ Microbiol (2007) 1.14
Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother (2009) 1.12
The survival of foodborne pathogens during domestic washing-up and subsequent transfer onto washing-up sponges, kitchen surfaces and food. Int J Food Microbiol (2003) 1.12
Phase-variable surface structures are required for infection of Campylobacter jejuni by bacteriophages. Appl Environ Microbiol (2006) 1.11
Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. J Antimicrob Chemother (2012) 1.08
Genome and transcriptome adaptation accompanying emergence of the definitive type 2 host-restricted Salmonella enterica serovar Typhimurium pathovar. MBio (2013) 1.06
The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob Agents Chemother (2008) 1.05
Campylobacter jejuni-induced cytokine responses in avian cells. Infect Immun (2005) 1.04
Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones. J Antimicrob Chemother (2003) 1.01
Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways. J Antimicrob Chemother (2009) 1.00
Prevalence and subtypes of ciprofloxacin-resistant Campylobacter spp. in commercial poultry flocks before, during, and after treatment with fluoroquinolones. Antimicrob Agents Chemother (2005) 0.99
Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select. Antimicrob Agents Chemother (2011) 0.99
Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin. Antimicrob Agents Chemother (2006) 0.98
Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother (2009) 0.97
Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother (2010) 0.97
Emergence of fluoroquinolone resistance in the native Campylobacter coli population of pigs exposed to enrofloxacin. J Antimicrob Chemother (2004) 0.97
Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria. Int J Antimicrob Agents (2010) 0.96
Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2010) 0.96
Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J Antimicrob Chemother (2010) 0.95
Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol (2014) 0.94
Comparison of pulsed-field gel electrophoresis and amplified fragment length polymorphism techniques for investigating outbreaks of enteritis due to campylobacters. J Clin Microbiol (2002) 0.93
A method for generating marker-less gene deletions in multidrug-resistant Acinetobacter baumannii. BMC Microbiol (2013) 0.93
Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother (2004) 0.93
Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob Chemother (2013) 0.93
Periplasmic adaptor protein AcrA has a distinct role in the antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother (2009) 0.92
Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland. Emerg Infect Dis (2009) 0.92
Direction of neutrophil movements by Campylobacter-infected intestinal epithelium. Microbes Infect (2010) 0.92
Persistence of transferable extended-spectrum-β-lactamase resistance in the absence of antibiotic pressure. Antimicrob Agents Chemother (2012) 0.91
Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli. Antimicrob Agents Chemother (2006) 0.89
Role of the alternative sigma factors sigmaE and sigmaS in survival of Salmonella enterica serovar Typhimurium during starvation, refrigeration and osmotic shock. Microbiology (2007) 0.89
Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates. Antimicrob Agents Chemother (2005) 0.89
Fluoroquinolone resistance in Haemophilus influenzae. J Antimicrob Chemother (2003) 0.89
Alternative explanation for indole-induced antibiotic tolerance in Salmonella. Proc Natl Acad Sci U S A (2013) 0.89
Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrob Agents Chemother (2004) 0.89
The TCA cycle is not required for selection or survival of multidrug-resistant Salmonella. J Antimicrob Chemother (2011) 0.89
Investigating vomiting and/or bloody diarrhoea in Campylobacter jejuni infection. J Med Microbiol (2006) 0.88
Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. J Antimicrob Chemother (2007) 0.88
Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium. J Antimicrob Chemother (2009) 0.88
Choice of bacterial growth medium alters the transcriptome and phenotype of Salmonella enterica Serovar Typhimurium. PLoS One (2013) 0.87
Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance. MBio (2013) 0.86
Dissemination of pCT-like IncK plasmids harboring CTX-M-14 extended-spectrum β-lactamase among clinical Escherichia coli isolates in the United Kingdom. Antimicrob Agents Chemother (2012) 0.86
A longitudinal study simultaneously exploring the carriage of APEC virulence associated genes and the molecular epidemiology of faecal and systemic E. coli in commercial broiler chickens. PLoS One (2013) 0.86
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni. Antimicrob Agents Chemother (2009) 0.85
Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother (2008) 0.85
Fitness and dissemination of disinfectant-selected multiple-antibiotic-resistant (MAR) strains of Salmonella enterica serovar Typhimurium in chickens. J Antimicrob Chemother (2007) 0.84
Antibacterial terpenes from the oleo-resin of Commiphora molmol (Engl.). Phytother Res (2008) 0.84
Overexpression of marA, soxS and acrB in veterinary isolates of Salmonella enterica rarely correlates with cyclohexane tolerance. J Antimicrob Chemother (2006) 0.84
RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease. J Antimicrob Chemother (2013) 0.84
Filament formation by Salmonella spp. inoculated into liquid food matrices at refrigeration temperatures, and growth patterns when warmed. J Food Prot (2003) 0.83
Effect of fluoroquinolone exposure on the proteome of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother (2006) 0.83
Exploiting the role of TolC in pathogenicity: identification of a bacteriophage for eradication of Salmonella serovars from poultry. Appl Environ Microbiol (2010) 0.82
Evidence for multiple-antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF. Antimicrob Agents Chemother (2005) 0.82
Pathogens on meat and infection in animals - Establishing a relationship using campylobacter and salmonella as examples. Meat Sci (2006) 0.81
Regional and global changes in TCRalphabeta T cell repertoires in the gut are dependent upon the complexity of the enteric microflora. Dev Comp Immunol (2009) 0.81
Regulation of RamA by RamR in Salmonella enterica serovar Typhimurium: isolation of a RamR superrepressor. Antimicrob Agents Chemother (2012) 0.79
Multiple redundant stress resistance mechanisms are induced in Salmonella enterica serovar Typhimurium in response to alteration of the intracellular environment via TLR4 signalling. Microbiology (2009) 0.79
Amoxicillin therapy of poultry flocks: effect upon the selection of amoxicillin-resistant commensal Campylobacter spp. J Antimicrob Chemother (2009) 0.77
Modification of enrofloxacin treatment regimens for poultry experimentally infected with Salmonella enterica serovar Typhimurium DT104 to minimize selection of resistance. Antimicrob Agents Chemother (2006) 0.77
Detection of Campylobacter jejuni and Campylobacter coli from broiler chicken-related samples using BAX PCR and conventional International Organization for Standardization culture. J Food Prot (2008) 0.77
Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression. J Antimicrob Chemother (2005) 0.77
Exposure of Campylobacter jejuni to 6 degrees C: effects on heat resistance and electron transport activity. J Food Prot (2010) 0.76
Post-therapy multiply resistant mutant of Pseudomonas aeruginosa. J Antimicrob Chemother (2002) 0.75
The response of Campylobacter jejuni to low temperature differs from that of Escherichia coli. Appl Environ Microbiol (2009) 0.75
European Antibiotic Awareness Day and access to antibiotics. BMJ (2012) 0.75
Antibiotics in media for isolation of Campylobacter spp. do not enhance resistance. J Antimicrob Chemother (2004) 0.75
Enrichment culture for the isolation of Campylobacter spp: Effects of incubation conditions and the inclusion of blood in selective broths. Int J Food Microbiol (2009) 0.75
Is Campylobacter jejuni enteritis a weekend disease? J Infect (2005) 0.75
Contribution of efflux to antibiotic resistance in Campylobacter isolated from poultry in Senegal. J Antimicrob Chemother (2009) 0.75